Nordea upgraded Genmab (GMAB) to Buy from Hold with a DKK 2,009 price target The shares are undervalued with potential “pipeline triggers” ahead, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GMAB: